BioCentury
ARTICLE | Clinical News

Amira preclinical data

January 12, 2009 8:00 AM UTC

AM211 demonstrated a good safety profile in dog and rat GLP toxicity studies. The company plans to submit an IND this half. AM211 is an oral small molecule antagonist of prostaglandin D2 (PGD2) recep...